|
⚲
|
| Keyboard |
| Harmon J Frank
✚
|
|
|---|---|
| CIK # | 0001364845 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001364845] | |
| 4 | [0001364845] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sagent Pharmaceuticals Inc | |
| Harmon J Frank |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Sagent Pharmaceuticals Inc SGNT
Common Stock
|
2016-08-29 | Disposed to issuer | 8,915 | $21.75 | 193,901 |
|
Sagent Pharmaceuticals Inc SGNT
Stock Option to Buy · derivative
|
2016-08-29 | Disposed to issuer | 18,897 | $8.29 | 156,656 |
|
Sagent Pharmaceuticals Inc SGNT
Common Stock
|
2016-03-14 | Grant | 8,915 | $0.00 | |
|
Sagent Pharmaceuticals Inc SGNT
Stock Option to Buy · derivative
|
2016-03-14 | Grant | 18,897 | $0.00 |